Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Friedman

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Vox Sanguinis|December 5, 2020
A microfluidic analysis of thrombus formation in reconstituted whole blood samples comparing spray-dried plasma versus fresh frozen plasmaRachel S Bercovitz, Caleb S Drew, Chana L Bushee, et al.
World Journal for Pediatric & Congenital Heart Surgery|October 18, 2014
Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature reviewJohn P Costello, Yaser A Diab, Michael Philippe-Auguste, et al.
Annals of Blood|August 24, 2018
Von Willebrand disease in the United States: perspective from the Zimmerman programVeronica H Flood, Thomas C Abshire, Pamela A Christopherson, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Thrombosis and Haemostasis|January 10, 2014
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levelsSuzanne J Francart, Emily M Hawes, Allison M Deal, et al.
Blood|December 15, 2010
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWDVeronica H Flood, Joan Cox Gill, Patricia A Morateck, et al.
Clinical Chemistry|January 24, 2013
Collagen binding provides a sensitive screen for variant von Willebrand diseaseVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2023
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety studyMichael D Tarantino, Brandon Hardesty, Ara Metjian, et al.
Molecular Genetics and Metabolism|December 3, 2005
Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysisJustin K Kakela, Kenneth D Friedman, Sandra L Haberichter, et al.
Blood|May 20, 2004
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surfaceBrian Boylan, Hong Chen, Vipul Rathore, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Vox Sanguinis|December 5, 2020
A microfluidic analysis of thrombus formation in reconstituted whole blood samples comparing spray-dried plasma versus fresh frozen plasmaRachel S Bercovitz, Caleb S Drew, Chana L Bushee, et al.
World Journal for Pediatric & Congenital Heart Surgery|October 18, 2014
Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature reviewJohn P Costello, Yaser A Diab, Michael Philippe-Auguste, et al.
Annals of Blood|August 24, 2018
Von Willebrand disease in the United States: perspective from the Zimmerman programVeronica H Flood, Thomas C Abshire, Pamela A Christopherson, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Thrombosis and Haemostasis|January 10, 2014
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levelsSuzanne J Francart, Emily M Hawes, Allison M Deal, et al.
Blood|December 15, 2010
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWDVeronica H Flood, Joan Cox Gill, Patricia A Morateck, et al.
Clinical Chemistry|January 24, 2013
Collagen binding provides a sensitive screen for variant von Willebrand diseaseVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2023
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety studyMichael D Tarantino, Brandon Hardesty, Ara Metjian, et al.
Molecular Genetics and Metabolism|December 3, 2005
Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysisJustin K Kakela, Kenneth D Friedman, Sandra L Haberichter, et al.
Blood|May 20, 2004
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surfaceBrian Boylan, Hong Chen, Vipul Rathore, et al.
Pageof 5